BIO89-100-132 The ENLIGHTEN-Cirrhosis Study
The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis stage F4 MASH [previously known as nonalcoholic steatohepatitis, NASH]).
- Investigator
- Ginger Clark
- Status
- Accepting Candidates
- Ages
- Adults
- Sexes
- All
TAK-999-5008 Non-Interventional Observational AATD study
- Investigator
- Ginger Clark
- Status
- Accepting Candidates
- Ages
- Adults
TAK-999-3003
The liver produces a protein called alpha-1 antitrypsin (AAT) which is released into the bloodstream. In some people, the liver makes an abnormal version of AAT, called Z-AAT. Z-AAT builds up in liver cells, and over time may lead to liver scarring…
- Investigator
- Ginger Clark
- Status
- Accepting Candidates
- Ages
- Adults
- Sexes
- All